CLINICAL TRIAL: PK STUDY OF INTRANODAL INJECTION OF ADENOVIRUS-CD154 IN PATIENTS

临床试验：腺病毒-CD154节内注射患者体内的药代动力学研究

• 批准号: 7724945
• 负责人: JANUARIO E CASTRO
• 金额: $ 0.55万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-12-01 至 2008-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7724945
• 关键词: Adenoviruses; Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Dose; Funding; Grant; Injection of therapeutic agent; Institution; Patients; Research; Research Personnel; Resources; Safety; Source; United States National Institutes of Health; lymph nodes

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Determine the safety and maximun tolerated dose of Adenovirus-CD154 (AD-ISF35) when injected directly into the lymph nodes of patients with CLL/SLL.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 当直接注入CLL/SLL患者的淋巴结中时，确定腺病毒CD154（AD-FISF35）的安全性和最大耐受剂量。